Expertise in
2
conditions

Dr. Susan T. Iannaccone

Pediatrics
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 

Overview

Susan Iannaccone is a Pediatrics provider practicing medicine in Dallas, Texas.

Dr. Iannaccone is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Muscle Atrophy, Hypotonia, Delayed Growth, Thymectomy, and Gastrostomy.

She is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 10 clinical trials.

Specialties

Pediatrics

Licenses

Psychiatry & Neurology in TX

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

University of Texas Southwestern Medical Center
5323 Harry Hines Blvd, Dallas, TX 75390

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Drug, Other
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Phase: Phase 3
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
Enrollment Status: Terminated
Publish Date: January 26, 2026
Intervention Type: Biological
Study Phase: Phase 1
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 2
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Enrollment Status: Terminated
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 2
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ataluren (PTC124®) in Patients Aged ≥2 to <5 Years Old With Nonsense Mutation Dystrophinopathy
A Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ataluren (PTC124®) in Patients Aged ≥2 to <5 Years Old With Nonsense Mutation Dystrophinopathy
Enrollment Status: Completed
Publish Date: August 28, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: December 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

76 Total Publications

Estimating Utility Values Using the DMD-QoL: A Disease-Specific Preference-Based Measure for Duchenne Muscular Dystrophy (DMD).
Estimating Utility Values Using the DMD-QoL: A Disease-Specific Preference-Based Measure for Duchenne Muscular Dystrophy (DMD).
Journal: Advances in therapy
Published: April 23, 2026
Similar Doctors
Expertise in
25
conditions
Dr. Craig A. Peters
Pediatrics | Urology
Expertise in
25
conditions
Dr. Craig A. Peters
Pediatrics | Urology
Referral may be required
Before you request

UT Southwestern - Pediatric Urology

2350 N. Stemmons Fwy., Ste. 4300, 
Dallas, TX 
 (0.4 miles away)
214-456-2444
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Craig Peters is a Pediatrics specialist and a Urologist practicing medicine in Dallas, Texas. Dr. Peters is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hydronephrosis, UPJ Obstruction, Testicular Torsion, Orchiectomy, and Endoscopy. Dr. Peters is currently accepting new patients.

Expertise in
37
conditions
Dr. Bruce J. Schlomer
Pediatrics | Urology
Expertise in
37
conditions
Dr. Bruce J. Schlomer
Pediatrics | Urology
Referral may be required
Before you request

Texas Scottish Rite Hospital For Children

5700 Dallas Pkwy, 
Frisco, TX 
 (21.7 miles away)
469-515-7100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bruce Schlomer is a Pediatrics specialist and a Urologist practicing medicine in Frisco, Texas. Dr. Schlomer is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Testicular Torsion, Hypospadias, Neurogenic Bladder, Reconstructive Urology Surgery, and Orchiectomy. Dr. Schlomer is board certified in Pediatric Urology- American Board Of Urology, Pediatric Urology- American Board Of Urology/Pediatric Urology, and Urology- American Board Of Urology. Dr. Schlomer is currently accepting new patients.

Expertise in
15
conditions
Dr. David M. Troendle
Pediatric Gastroenterology | Pediatrics
Expertise in
15
conditions
Dr. David M. Troendle
Pediatric Gastroenterology | Pediatrics
Referral may be required
Before you request

UT Southwestern - Pediatric Gastroenterology

5323 Harry Hines Blvd, 
Dallas, TX 
 (0.1 miles away)
214-456-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Troendle is a Pediatric Gastroenterologist and a Pediatrics provider practicing medicine in Dallas, Texas. Dr. Troendle is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Childhood Pancreatitis, Chronic Pancreatitis, Hereditary Pancreatitis, Endoscopy, and Gallbladder Removal. Dr. Troendle is currently accepting new patients.

Frequently Asked Questions about Dr. Susan T. Iannaccone

How do I make an appointment with Dr. Susan T. Iannaccone?

You can book an appointment with Dr. Susan T. Iannaccone by calling their office at 214-456-2768. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Susan T. Iannaccone a top-rated expert for Muscle Atrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Susan T. Iannaccone is classified as an Distinguished expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Susan T. Iannaccone specialize in?

While Dr. Susan T. Iannaccone is a Pediatrics, they have specific expertise in Muscle Atrophy, Hypotonia, and Thymectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Susan T. Iannaccone participate in research or clinical trials?

Yes. Dr. Susan T. Iannaccone has published 76 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Dr. Susan T. Iannaccone's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Susan T. Iannaccone accept my insurance?

Dr. Susan T. Iannaccone accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-456-2768 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Iannaccone's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile